# 바이오스페이스 일일 뉴스 리포트 - 2025년 11월 05일


## 주요 헤드라인

1. **Pfizer Fields Novo’s $10B Curveball, With Bourla Promising To Fight for Metsera (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/pfizer-fields-novos-10b-curveball-with-bourla-promising-to-fight-for-metsera>

2. **Pfizer Fields Novo’s $10B Curveball, With Bourla Promising To Fight for Metsera (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/pfizer-fields-novos-10b-curveball-with-bourla-promising-to-fight-for-metsera>

3. **Novo Ups Ante in Metsera Buyout Drama With $10B Offer, Beating Pfizer’s New Bid (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-ups-ante-in-metsera-buyout-drama-with-10b-offer-beating-pfizers-new-bid>

4. **Novo Ups Ante in Metsera Buyout Drama With $10B Offer, Beating Pfizer’s New Bid (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-ups-ante-in-metsera-buyout-drama-with-10b-offer-beating-pfizers-new-bid>

5. **Vertex’s New Products Dim as Analysts Eye Kidney Portfolio (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/vertexs-new-products-dim-as-analysts-eye-kidney-portfolio>

6. **Vertex’s New Products Dim as Analysts Eye Kidney Portfolio (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/vertexs-new-products-dim-as-analysts-eye-kidney-portfolio>

7. **Sarepta’s DMD Exon-Skippers Fail Confirmatory Study, Stock Craters (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/sareptas-dmd-exon-skippers-fail-confirmatory-study-stock-craters>


---
*2025년 11월 05일 바이오스페이스 뉴스 피드에서 생성된 리포트*